Recent studies have demonstrated the role of FGF21 in the regulation of glucose and lipid metabolism as well as its possible impact on the treatment of diabetes and obesity (Smith et al., 2013[14]). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.